Mapping of Dopamine D₃ Receptor Binding Site by Pharmacological Characterization of Mutants Expressed in Cho Cells with the Semliki Forest Virus System

References

• Schenker E., Herbst H. Progress in Drug Research, E. Jucker. Birkhauser, Basel 1963; 269–280
   Google Scholar
• Carlsson A. Some aspects of dopamine in the central nervous system. Adv. Neurol. 1974; 5: 59–68
   Google Scholar
• Sokoloff P., Giros B., Martres M.-P., Bouthenet M.-L., Scwartz J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347: 146–151
   PubMed Web of Science ®Google Scholar
• Civelli O., Burzon J. R., Grandy D. K., Zhou Q.-J., Van Tol. H.H.M. Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 1991; 207: 277–286
   PubMed Web of Science ®Google Scholar
• Sunahara R. K., Guan H. C., O'Doud B. F., Seeman P., Laurier L. G., Ng G., George S.-R., Torchia J., Van Tol. H.H.M., Hubert H. M., Niznik H. G. Cloning of the gene for a human dopamine D5receptor with higher affinity for dopamine than D1. Nature 1991; 350: 614–619
   PubMed Web of Science ®Google Scholar
• Jenno P., Marsden C. D. Drugs in Central Nervous System Disorders, D.C. Horvell. Marcel Dekker, New York 1985; 149–262
   Google Scholar
• Landwehrmeyer B., Mengod G., Palacios J. M. Dopamine D3receptor mRNA and binding sites in human brain. Brain Res. Mol. Brain Res. 1993; 18: 187–192
   PubMedGoogle Scholar
• Sokoloff P., Martres M.-P., Giros B., Bouthenet M.-L., Schwarz J. C. The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem. Pharmacol. 1992; 43: 659–666
   PubMed Web of Science ®Google Scholar
• Sokoloff P., Diaz J., Levesque D., Pilon C., Dimitriadou V., Griffon N., Lammers C. H., Martres M.-P., Schwarz J. C. Novel dopamine receptor subtypes as targets for antipsychotic drugs Ann. N.Y. Acad. Sci. 1995; 757: 278–292
   Google Scholar
• Schwarz J. C., Levesque D., Martres M.-P., Sokoloff P. Dopamine D3receptor: basic and clinical aspects. Clin. Neuropharmacol. 1993; 16: 295–314
   Google Scholar
• Liljestrom P., Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 1991; 9: 1356–1361
   PubMed Web of Science ®Google Scholar
• Henderson R., Baldwin J. M., Ceska T. A. Model for the structure of bacteriorhodopsin based on high resolution electron cryo-microscopy. J. Mol. Biol. 1990; 213: 899–929
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning. A laboratory manual. Cold Spring Harbor, New York 1982
   Google Scholar
• Lundstrom K., Turpin M. P. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3receptor with the Semliki Forest virus system. Biochem. Biophys. Res. Comm. 1996; 225: 1068–1072
   PubMed Web of Science ®Google Scholar
• Lundstrom K., Ahti H., Ulmanen I. Site-directed mutagenesis and protein engineering, M.P. El-Gewely. Elsevier Science Publisher, Amsterdam 1991; 119–122
   Google Scholar
• Berglund P., Sjoberg M., Garoff H., Atkins G. J., Sheahan B. J., Liljestrom P. Semliki Forest virus expression system: Production of conditionally infectious recombinant particles. Bio/Technology 1993; 11: 916–920
   PubMed Web of Science ®Google Scholar
• Lundstrom K., Mills A., Buell G., Allet E., Adami N., Liljestrom P. High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system. Eur. J. Biochem. 1994; 224: 917–921
   PubMedGoogle Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Bylund D. B., Yamamura H. I. Methods in neurotransmitter receptor analysis, H.I. Yamamura, S.J. Enna, M.J. Kuhar. Raven Press, New York 1990; 1–35
   Google Scholar
• Murray P. J., Helden R. M., Johnson M. R., Robertson G. M., Scopes D. I.C., Stokes M., Wadman S., Whitehead J. W.F., Hayes A. G., Kilpatrick G. J., Large C., Stubbs C., Turpin M. Novel 6-substituted 2-aminotetralins with potent and selective affinity for the dopamine D3receptor. Bioorg. & Med. Chem. Lett. 1995; 6: 403–408
   Google Scholar
• Murray P. J., Harrison L. A., Johnson M. R., Robertson G. M., Scopes D. I.C., Bull D. R., Graham E. A., Hayes A. G., Den Kilpatrick G. J., Daas I., Large C., Sheehan M. J., Stubbs C. M., Turpin M. P. A novel series of arylpiperazines with high affinity and selectivity for the dopamine D3receptor. Bioorg. & Med. Chem. Lett. 1995; 5: 219–222
   Google Scholar
• Rovati G. E., Rodbard D., Munson P. J. DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites. Anal. Biochem. 1988; 174: 636–649
   Google Scholar
• Lewell X. Q. A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. Drug Des. Discov. 1992; 9: 38–48
   Google Scholar
• Mansour A., Meng F., Meador-Woodruff J. H., Taylor L. P., Civelli O., Akil H. Site-directed mutagenesis of the dopamine D2receptor. Eur. J. Pharmacol. 1992; 227: 205–214
   PubMed Web of Science ®Google Scholar
• Wheeler T. N., Blanchard S. G., Andrews R. C., Fang F., Gray-Nunez Y., Harris C. O., Lambert M. H., Mehrotra M. M., Parks D. J., Ray J. A., Smalley T. L. Substrate specificity in short-chain phospholipid analogs at the active site of human synovial phospholipase A2. J. Med. Chem. 1994; 37: 4118–4129
   PubMed Web of Science ®Google Scholar
• Cox B. A., Henningsen R. A., Spanoyannis A., Neve R. L., Neve K. A.J. Contributions of conserved serine residues to the interactions of ligands with dopamine D2Receptors. J. Neurochem. 1992; 59: 627–635
   Google Scholar
• Guan X. M., Peroutka S. J., Kobilka B. K. Identification of a single amino acid residue responsible for the binding of a class of β-adrenergic receptor antagonists to 5-hydroxytryptamine 1A receptors. Mol. Pharmacol. 1992; 41: 695–698
   PubMed Web of Science ®Google Scholar
• Norman D. A., Naylor L. H. Studies on a chimeric rat D2-D3dopamine receptor. Biochem Soc. Trans. 1994; 27: 14–35
   Google Scholar